LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)
Hong Kong · Delayed Price · Currency is HKD 14.68
+2.50 (20.53%)
Aug 21, 2026, 4:08 PM HKT
HKG:2291 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 507.91 | 527.47 | 471.14 | 325.9 | 247.67 | 222.58 |
Other Revenue | 0.47 | 0.47 | 0.5 | 0.73 | - | - |
| 508.38 | 527.94 | 471.64 | 326.62 | 247.67 | 222.58 | |
Revenue Growth | -7.94% | 11.94% | 44.40% | 31.88% | 11.27% | 50.14% |
Cost of Revenue | 91.31 | 80.99 | 47.61 | 37.53 | 27.98 | 25.04 |
Gross Profit | 417.06 | 446.95 | 424.03 | 289.09 | 219.69 | 197.55 |
Selling, General & Admin | 142.03 | 134.92 | 106.77 | 87.5 | 71.91 | 70.26 |
Research & Development | 52.34 | 58.15 | 57.99 | 62.07 | 53.87 | 41.39 |
Other Operating Expenses | -12.45 | -5.22 | -3.27 | -7.37 | -17.74 | -10.78 |
Operating Expenses | 186.46 | 190.15 | 168.47 | 136.21 | 113.72 | 101.8 |
Operating Income | 230.6 | 256.81 | 255.56 | 152.88 | 105.97 | 95.75 |
Interest Expense | -0.12 | -0.12 | -0.16 | -0.14 | -18.97 | -11.55 |
Interest & Investment Income | 23.47 | 23.48 | 28.84 | 25.58 | 5.67 | 7.85 |
Currency Exchange Gain (Loss) | -3.52 | -3.52 | 1.96 | -5.89 | -82.28 | 5.19 |
Other Non Operating Income (Expenses) | -14.47 | -0.2 | -0.14 | 0.6 | -0.05 | 1.47 |
EBT Excluding Unusual Items | 235.97 | 276.46 | 286.06 | 173.04 | 10.34 | 98.72 |
Gain (Loss) on Sale of Investments | - | - | - | - | -4.93 | - |
Gain (Loss) on Sale of Assets | 0.02 | - | 0.03 | - | - | - |
Asset Writedown | - | - | - | - | -0 | -0 |
Other Unusual Items | - | - | - | - | -20.44 | -32.69 |
Pretax Income | 235.98 | 276.46 | 286.09 | 173.04 | -15.03 | 66.03 |
Income Tax Expense | 31.74 | 36.74 | 40.53 | 21.66 | 4.78 | 7.33 |
Net Income | 204.24 | 239.73 | 245.56 | 151.38 | -19.81 | 58.7 |
Net Income to Common | 204.24 | 239.73 | 245.56 | 151.38 | -19.81 | 58.7 |
Net Income Growth | -28.92% | -2.38% | 62.22% | - | - | -14.65% |
Shares Outstanding (Basic) | 347 | 347 | 347 | 347 | 328 | 304 |
Shares Outstanding (Diluted) | 347 | 347 | 347 | 347 | 328 | 304 |
Shares Change | -0.00% | - | - | 5.86% | 7.79% | 9.63% |
EPS (Basic) | 0.59 | 0.69 | 0.71 | 0.44 | -0.06 | 0.19 |
EPS (Diluted) | 0.59 | 0.69 | 0.71 | 0.44 | -0.06 | 0.19 |
EPS Growth | -29.09% | -2.57% | 62.22% | - | - | -22.14% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 144.66 | 137.05 | 66.75 | 52.25 | 82.83 |
Free Cash Flow Per Share | - | 0.42 | 0.40 | 0.19 | 0.16 | 0.27 |
Dividend Per Share | - | 0.500 | 0.620 | 0.570 | - | - |
Dividend Growth | - | -19.36% | 8.77% | - | - | - |
Gross Margin | 82.04% | 84.66% | 89.91% | 88.51% | 88.70% | 88.75% |
Operating Margin | 45.36% | 48.64% | 54.19% | 46.81% | 42.79% | 43.02% |
Profit Margin | 40.18% | 45.41% | 52.06% | 46.35% | -8.00% | 26.37% |
Free Cash Flow Margin | - | 27.40% | 29.06% | 20.44% | 21.10% | 37.21% |
EBITDA | 267.93 | 292.6 | 262.2 | 158.89 | 117.99 | 103.88 |
EBITDA Margin | 52.70% | 55.42% | 55.59% | 48.65% | 47.64% | 46.67% |
D&A For EBITDA | 37.33 | 35.79 | 6.64 | 6.01 | 12.02 | 8.13 |
EBIT | 230.6 | 256.81 | 255.56 | 152.88 | 105.97 | 95.75 |
EBIT Margin | 45.36% | 48.64% | 54.19% | 46.81% | 42.79% | 43.02% |
Effective Tax Rate | 13.45% | 13.29% | 14.17% | 12.52% | - | 11.10% |
Revenue as Reported | 508.38 | 527.94 | 471.64 | 326.62 | - | - |
Advertising Expenses | - | 3.36 | 3.25 | 3.19 | - | - |